Materials • Major Chemicals
$311.75 ▲ +4.55
(+1.48%)
MKT CAP: $69.42B • VOL: 1.28M
52W L $229 52W H $317
APD // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $12.04B | $12.10B | $12.60B |
| YoY Revenue Growth % | -0.5% | -4.0% | — |
| Gross Profit | $3.78B | $3.93B | $5.54B |
| Gross Margin % | 31.4% | 32.5% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$877.0M | $4.47B | $2.49B |
| Operating Margin % | -7.3% | 36.9% | 19.8% |
| Net Income (GAAP) | -$394.5M | $3.83B | $2.30B |
| EBITDA (Normalized) | $4.74B | $9.90B | $2.95B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$441.8M | $4.29B | $2.58B |
| Capital Expenditures (CapEx) | $7.02B | $6.80B | $567.0M |
| Free Cash Flow (FCF) | -$7.46B | -$2.51B | $2.01B |
| FCF Margin % | -62.0% | -20.7% | 15.9% |
| Return on Invested Capital (ROIC %) | -2.8% | 14.4% | 8.5% |
| Cash & Short-Term Equivalents | $1.03B | $1.85B | $4.20B |
| Total Debt (Short + Long Term) | $10.53B | $9.58B | $8.93B |
| Total Stockholders' Equity | $15.41B | $16.69B | $18.33B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR APD.